Publicacións en colaboración con investigadores/as de Universidade da Coruña (22)

2022

  1. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies

    Frontiers in Medicine, Vol. 9

2020

  1. All-trans retinoic acid inhibits migration and invasiveness of rheumatoid fibroblast-like synoviocytes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 372, Núm. 2, pp. 185-192

  2. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

2019

  1. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

    PLoS ONE, Vol. 14, Núm. 2

  2. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

2018

  1. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS ONE, Vol. 13, Núm. 5

2016

  1. A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 55, Núm. 6, pp. 1106-1111

  2. Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study

    Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1384-1391

  3. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140

  4. Specific premature epigenetic aging of cartilage in osteoarthritis

    Aging, Vol. 8, Núm. 9, pp. 2222-2231

2015

  1. Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

2014

  1. A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2130-2136

  2. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies

    Arthritis and Rheumatology, Vol. 66, Núm. 4, pp. 940-949

  3. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

  4. Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study

    Arthritis Research and Therapy, Vol. 16, Núm. 1

2012

  1. Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Actualización 2011 del consenso Sociedad Española de Reumatología de osteoporosis

    Reumatologia Clinica, Vol. 7, Núm. 6, pp. 357-379

  2. Association of systemic lupus erythematosus clinical features with european population genetic substructure

    PLoS ONE, Vol. 6, Núm. 12

  3. Insights into the genetic architecture of osteoarthritis from stage 1 of the arcOGEN study

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 5, pp. 864-867

2010

  1. Common variations in estrogen-related genes are associated with severe large-joint osteoarthritis: A multicenter genetic and functional study

    Osteoarthritis and Cartilage, Vol. 18, Núm. 7, pp. 927-933